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Abstract
The abdomen is the second most common source of sepsis and secondary peritonitis. The most common causes of 
abdominal sepsis are perforation, ischemic necrosis or penetrating injury to the abdominal viscera. Management 
consists of control of the infection source, restoration of gastrointestinal tract (GI) function, systemic antimicrobial 
therapy and support of organ function. Mortality after secondary peritonitis is still high. Excluding patient-related 
factors such as age or co-morbidities that can not be influenced at the time of intervention, delay to surgical inter-
vention and inability to obtain source control are the main determinants of outcome. In patients with severe physi-
ological derangement or difficult intraperitoneal conditions, where a prolonged operation and complete anatomical 
repair may not be possible or appropriate, it is becoming increasingly popular to utilize a damage control strategy 
with abbreviated laparotomy and planned reoperations. The main components of damage control laparotomy for 
secondary peritonitis are postponing the reconstruction of intestinal anastomoses to a second operation (deferred 
anastomosis) and leaving the abdomen open with some form of temporary abdominal closure (TAC). Advances in 
the management techniques of the open abdomen and new negative pressure-based TAC-devices have significantly 
reduced the previously observed prohibitive morbidity associated with open abdomens. These advancements have 
led to current fascial closure rates after TAC approaching 90%. The cornerstones of appropriate antimicrobial therapy 
are the timing, spectrum and dosing of antibiotics. Enteral nutrition should be started as soon as possible in hemo-
dynamically stable patients but withheld when the patient is on a significant dose of vasopressors or whenever GI 
hypoperfusion is suspected. Timely source control with appropriate use of antimicrobial agents and early intensive 
care offers the best chance of survival for patients with abdominal sepsis. The introduction of the concept of damage 
control to the management of secondary peritonitis represents a paradigm shift in the same way as in management of 
major trauma. Although limited and repeated surgical interventions have been shown to be safe, the actual benefits 
need to be demonstrated in controlled studies.
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Following pulmonary sepsis, abdominal sepsis is the sec-
ond most common form of sepsis requiring intensive care 
unit (ICU) management. In a nation-wide survey of ICU-treat-
ed adults with severe sepsis in Finland, an intra-abdominal 
source was found in 32% of patients and was associated 
with a hospital mortality rate of 32% [1].
When systemic inflammatory response syndrome (SIRS) 
is due to infection, it is termed sepsis, and sepsis caused 
by an intra-abdominal infection (IAI) is termed abdominal 
sepsis. Sepsis with acute dysfunction of at least one organ is 
called severe sepsis, and severe sepsis with hemodynamic 
instability refractory to fluid administration, with a require-
ment for vasopressor support is termed septic shock [2].
In uncomplicated forms of IAI, the infection is contained 
within a single organ and rarely causes critical illness. Com-
plicated IAIs extend beyond the source organ and into the 
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peritoneal cavity and may progress to sepsis in approxi-
mately 40% of patients [2]. Contained infection results in the 
formation of an intra-abdominal abscess (Figs 1−2), whereas 
uncontained spread of infection leads to diffuse peritonitis.
Peritonitis is defined according to both its cause and 
extent and is usually divided into primary, secondary and 
tertiary peritonitis [2]. In primary peritonitis, there is no iden-
tifiable anatomic derangement of intra-abdominal viscera, 
whereas in secondary peritonitis the cause of the infection 
is in the abdominal viscera, as a consequence of either 
perforation, ischemic necrosis or penetrating injury. Tertiary 
peritonitis refers to situations where there has been no 
recovery from secondary peritonitis despite timely surgical 
intervention and appropriate antibiotics, and is sometimes 
associated with impaired host defenses.
A multicenter investigation performed in 68 medical insti-
tutions in Europe over a 6-month period identified a total of 
2,152 patients with complicated intra-abdominal infections 
with an overall mortality rate of 7.5% [3]. The independent 
variables predictive of mortality included patient age, pres-
ence of an intestinal non-appendicular source of infection, in-
tervention delay exceeding 24 hours, sepsis and septic shock 
in the immediate postoperative period, and ICU admission.
In another worldwide survey on complicated intra-ab-
dominal infections performed by the World Society of 
Emergency Surgery, 88% of the infectious episodes were 
community acquired and the remaining were nosocomial 
intra-abdominal infections [4]. Generalized peritonitis was 
observed in 43%, and 57% of the patients had localized 
peritonitis or abscesses. The overall mortality rate was 10%.
The basic principles in managing abdominal sepsis in-
clude source control, restoration of GI function, systemic 
antimicrobial therapy and support of organ function [2]. 
Source control consists of eliminating the source of the 
leakage by suturing or resecting the leak site, and evacu-
ating enteral content and pus by performing peritoneal 
lavage (Fig. 3). Although the prognosis of uncomplicated 
IAIs is good, in patients with severe sepsis or septic shock 
secondary to IAI, the mortality rate is about 25−35%, and 
may exceed 70%. A multitude of factors have been associ-
ated with mortality in secondary peritonitis such as shock, 
age, increasing APACHE II score, isolation of enterococci, 
impaired consciousness, inadequate empiric antibiotics, 
poor nutritional status, cardiovascular disease, immunosup-
pression, hypoalbuminemia, thrombocytopenia, diffuse 
vs. localized peritonitis, subsequent nosocomial infection 
and a protein C concentration below 66% of normal [2]. Ad-
ditional factors that have been identified such as elevated 
C-reactive protein (CRP) in the early postoperative phase 
[5] and an admission Sequential Organ Failure Assessment 
(SOFA) score for ICU patients [6], have prognostic signifi-
cance specifically in severe secondary peritonitis. 
Figure 1. CT of a patient with suphrenic abscess after 
cholecystectomy
Figure 2. Operative photo of the same patient with subphrenic 
absess
Figure 3. Peritoneal lavage
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Although most of these factors can not be influenced 
at the time of admission, there are two critical factors at the 
initial stages of sepsis that have a profound effect on survival 
and are the main focus of this review: a delay of definitive 
intervention more than 24 hours after symptoms started, 
and an inability to obtain source control at surgery. While 
the preoperative delay can be shortened with accurate 
diagnostics and rapid access to surgical care, these areas 
for improvement are beyond the scope of this review. The 
ability to achieve source control during the initial operation, 
the patient’s inability to tolerate extensive and prolonged 
surgical intervention, and the general options for surgical 
and intensive care will be further discussed below.
DAMAGE CONTROL
Various terminology including staged abdominal repair, 
abbreviated laparotomy and planned reoperation, and open 
abdomen have been applied in describing a surgical strat-
egy where an external trauma, acute disease processes or 
a (surgical) complication has lead to a severe physiological 
derangement of the patient. Occasionally the management 
of severe cases can require such extensive and prolonged 
surgery that some patients may succumb intraoperatively. 
In managing such severe cases the damage control ap-
proach allows for temporary control of the source of insult 
(whether bleeding or contamination) [7]. Leaving the abdo-
men open allows for the patient to be transferred to an ICU 
for restoration of homeostasis followed by return to the 
operation theatre 1−2 days later for the definitive repair of 
organ defects.
The first damage control maneuver described in the 
literature was the packing of the liver to control bleed-
ing from hepatic lacerations. Pringle in 1908 and Halsted 
in 1913 published the earliest descriptions of perihepatic 
packing for liver injury with severe bleeding [8, 9]. These 
observations were forgotten for several decades, until Stone 
and his co-workers published a series of 17 severely injured 
patients treated with abbreviated laparotomy and planned 
reoperation with a survival rate of 76% when compared 
with 14 similar patients undergoing definitive repair with 
only one survivor (7%) [10]. Damage control indications and 
techniques were refined by Ivatury in 1986 ([11] and Burch in 
1992 [12]. However, the term “damage control” — originat-
ing from naval warfare, where the water leak in a ship hit 
by hostile fire was temporary controlled with any available 
means to enable the ship to keep mobile and evade further 
damage — was first used by Rotondo, Schwab and their 
co-workers in 1993 [13].
The principles of damage control surgery — early tem-
porizing operation, leaving the abdomen open and planned 
reoperation with definitive repair — has recently been ex-
tended to other non-trauma surgical emergencies, such 
as the management of secondary peritonitis from bowel 
perforation, bowel ischemia, ruptured abdominal aortic 
aneurysm, and severe acute pancreatitis [14, 15].
In patients with secondary peritonitis, antibiotic loading 
and fluid resuscitation before laparotomy has beneficial ef-
fects on outcomes and these benefits are seen even for ab-
breviated surgical procedures [16−19]. This is fundamentally 
different from trauma and bleeding where there is often no 
time for resuscitation before surgery.
In peritonitis, a staged approach may be required for 
three different or often combined reasons: 
First, the septic source cannot be controlled adequately 
with a single operation. Instead of the traditional model 
of one definitive operation and possible reoperation only 
performed as needed (relaparotomy on-demand [ROD] 
strategy), there are two other options to manage a severely 
contaminated peritoneal cavity. One, termed planned re-
laparotomy (PR), refers to a technique where the need for 
a second operation is recognized during the initial opera-
tion. Another option, the open abdomen (OA) technique, re-
fers to leaving the abdomen open and treating the infected 
peritoneal cavity like an “open abscess” with frequent irriga-
tions and temporary abdominal closure (TAC) techniques.
Second, the patient does not tolerate definitive repair 
and/or abdominal wall closure. In this scenario, the opera-
tion is deliberately abbreviated due to the severe physiologi-
cal derangement and suboptimal local conditions for heal-
ing. Restoration of intestinal continuity is therefore deferred 
to the second operation (deferred anastomosis technique).
Third, the presence of extensive visceral edema (and 
occasionally packs left in the abdominal cavity for tem-
porary hemorrhage control) may risk the development of 
abdominal compartment syndrome (ACS), if primary fascial 
closure is attempted (Fig. 4). To prevent ACS, the abdominal 
incision is left open and the viscera are covered with one 
of the TAC methods. ACS can develop from a number of 
Figure 4. Measuring intra-abdominal pressure
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complications related to intra-abdominal sepsis including, 
but not limited to, large volume fluid resuscitation resulting 
in visceral edema and intra-abdominal free fluid collection; 
retroperitoneal, intra-abdominal and abdominal wall bleed-
ing; ileus; pseudo-obstruction and mechanical obstruction 
of the bowel.
SOURCE CONTROL IN ABDOMINAL SEPSIS
Source control is defined as any and all physical means 
necessary to eradicate a focus of infection, as well as the 
modification of factors that maintain infection, such as leak-
ing intestinal contents [2]. Source control is based on four 
principles: drainage, decompression, debridement and res-
toration of anatomy and function. All four principles can be 
applied independently, and at different moments in a single 
patient. In generalized peritonitis, laparotomy is the prin-
cipal method to achieve source control. In patients where 
sepsis is caused by a perforation in the gastrointestinal tract, 
the aim of source control is to eliminate ongoing leakage 
of luminal contents through the removal of the perforation 
or through the creation of a controlled sinus or fistula [20].
In abdominal sepsis a single operation is not always suf-
ficient to achieve source control and even if source control 
is achieved, a significant number of patients will develop 
complications necessitating a repeat laparotomy. Repeat 
laparotomy after any kind of abdominal surgery is required 
in about 2% of cases with the most common reason being 
leakage from an intestinal repair or anastomosis. In a se-
ries of 114 repeat laparotomies after abdominal surgery, 
intestinal leak was responsible for 30% of the reoperations 
with a mortality rate of 31% [21]. Postoperative peritonitis 
is associated with a mortality rate of 22−55% and is caused 
by the inability to control the septic source or clear the 
abdominal infection. Increased age and unconsciousness 
also contribute to this significant mortality rate [22]. Patients 
with duodenal leaks or fecal peritonitis are examples of 
conditions where it is sometimes difficult to achieve reli-
able source control
Because of the high mortality associated with second-
ary peritonitis especially in patients with inadequate source 
control, alternative strategies to a single operation with 
definitive repair and reoperations only as needed (ROD) 
were developed and include the PR and open abdomen 
(OA) strategies. Although a meta-analysis comparing ROD 
and PR was inconclusive [23], a retrospective analysis of 
278 patients by the same group showed that ROD was 
associated with higher in-hospital and long term survival 
rates, and was an independent predictor of survival [24]. 
A randomized study of 232 patients comparing these two 
treatment strategies showed no significant difference in 
the combination end point of all-cause mortality and ma-
jor disease-related morbidity in surviving patients within 
a 12-month follow-up after index laparotomy [25]. However, 
there was a substantial reduction in repeat laparotomies, 
health care utilization and medical costs with ROD.
It appears that PR does not improve outcome over ROD 
and may even aggravate the inflammatory response [26]. In 
addition, PR should be used with caution in patients with 
duodenal leaks [27].
During the 1970s OA or laparostomy became one of 
the options to manage severe secondary peritonitis. Obvi-
ously, laparostomy does not obviate the need for abdominal 
re-explorations which, in turn, are facilitated by leaving the 
abdomen open [28]. Prior to the development of modern 
TAC methods [29], bleeding, and especially enteric fistula 
complications, were common and mortality was close to 
40% [30, 31]. A randomized study comparing an obscure 
technique of OA (with nonabsorbable mesh and ROD) and 
the standard closed abdomen technique in severe second-
ary peritonitis was terminated at the first interim analysis 
due to higher mortality (55% vs. 30%) in the OA group [32].
Recent studies utilizing laparostomy with vacuum-as-
sisted closure methods in secondary peritonitis have shown 
that the technique is safe and is associated with a relatively 
high (up to 75%) fascial closure rate 33−36. Adding some 
form of mechanical traction to the vacuum-therapy seems to 
further increase the fascial closure rate in abdominal sepsis 
[37], as has been shown in other abdominal emergencies 
requiring OA to treat or prevent ACS, such as in severe 
acute pancreatitis and abdominal vascular emergencies 
[38−40]. Whether OA with modern TAC methods helps to 
clear the infection, attenuate the peritoneal inflammation, 
reduce the risk of organ failure and improve outcome is 
still controversial, but experimental data seems to point 
towards improved outcomes [41]. Clinical studies, however, 
have been equivocal. Although a systematic review of the 
literature on this topic found the overall evidence to be of 
poor quality but reported the highest closure rates and 
lowest fistula rates in patients treated with NPT combined 
with fascial traction [42].
More recently, Kirkpatrick et al. [43] randomized 45 pa-
tients (about half of them undergoing laparotomy for in-
tra-abdominal infection) after abbreviated laparotomy to 
NPT or Barker vacuum pack TAC and could not find any 
differences in inflammatory mediators.
ABBREVIATED LAPAROTOMY AND DEFERRED 
ANASTOMOSIS
In a retrospective cohort study from Cali, Colombia, 
112 patients with secondary peritonitis requiring bowel 
resection and managed with staged laparotomy were 
analyzed [44]. Deferred primary anastomosis was used in 
34 patients where the bowel ends were ligated at the first 
operation and definitive anastomoses were reconstructed 
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at the subsequent operation following physiological sta-
bilization in the ICU and repeated peritoneal washes until 
the septic source was controlled. In contrast, 78 patients 
underwent enteral or colonic diversion followed by similar 
ICU stabilization and peritoneal washes. In both groups, 
the abdomens were left open at the initial operation and 
a Velcro system or vacuum pack was used for temporary 
abdominal closure.
The mean number of laparotomies was four in both 
groups. There were more patients with colon resections in 
the diversion group (80% vs. 47%). There was no significant 
difference in hospital mortality (12% for deferred anastomo-
sis vs. 17% for diversion), frequency of anastomotic leaks or 
fistulas (9% vs. 5%), or acute respiratory distress syndrome 
(ARDS)(18% vs. 31%). The authors concluded that in critically 
ill patients with severe secondary peritonitis managed with 
staged laparotomies, deferred primary anastomosis can be 
performed safely as long as adequate control of the septic 
foci and restoration of deranged physiology is achieved 
prior to reconstruction.
Because this non-randomized study compared essen-
tially two different damage control techniques (control of 
contamination with temporary bowel ligation or diversion, 
and leaving the abdomen open), it does not answer the fun-
damental question of whether it is better to perform primary 
anastomosis at the initial operation or during a subsequent 
operation. What it does show, however, is that the deferred 
anastomosis technique is not associated with a prohibitive 
rate of anastomotic leak when compared with leaks or fis-
tulas associated with “semi-permanent” diversion.
In a non-randomized study of 27 consecutive patients 
with perforated diverticulitis (Hinchey III/IV), the patients 
were managed as follows: either with sigmoid resection 
and primary anastomosis (n = 6), limited sigmoid resec-
tion or suture, open abdomen and primary anastomosis 
or colostomy at the second operation 24−48 hours later 
(n = 15), or the Hartmann procedure; sigmoid resection 
and end colostomy (n = 6) [45]. Although all 6 patients with 
primary anastomosis survived without complications, there 
was an obvious selection bias. Of the 6 patients undergoing 
Hartmann’s procedure, one died of sepsis and 5 were dis-
charged with a stoma. In the interesting group of 15 patients 
with deferred anastomosis or stoma and open abdomen, 
9 patients had intestinal continuity restored during the 
second look operation with one fatal anastomotic leak. In 
addition, there were two patients with dehiscence of the 
abdominal closure and death from pneumonia and multiple 
organ failure, respectively.
In a prospective study of 51 patients with perforated 
diverticulitis (Hinchey III/IV), patients were initially managed 
with limited resection, lavage and TAC with vacuum-as-
sisted closure followed by second, reconstructive opera-
tion 24−48 hours later [46]. Bowel continuity was restored 
in 38 patients, with 4 protected by a loop ileostomy. Five 
anastomotic leaks (13%) were encountered requiring loop 
ileostomy (2 patients) or Hartmann’s procedure (3 patients). 
Postoperative abscesses were seen in 4 patients, and one 
case each of abdominal wall dehiscence and relaparotomy 
for drain-related small bowel perforation. The overall mortal-
ity rate was 10% and 35/46 (76%) of the surviving patients 
left the hospital with reconstructed colon continuity. Fascial 
closure was achieved in all patients.
It seems that the concept of damage control with lav-
age, limited bowel resection, open abdomen and delayed 
anastomosis is feasible in selected patients with secondary 
peritonitis after a sigmoid perforation. However, more stud-
ies are needed to examine the safety and potential benefit 
of deferring the construction of intestinal anastomoses to 
a later stage (after open abdomen) in patients with gener-
alized secondary peritonitis for perforated diverticulitis, as 
well as other causes.
ABDOMINAL COMPARTMENT SYNDROME AND 
ABDOMINAL SEPSIS
The incidence of intra-abdominal hypertension (IAH) or 
ACS in patients with secondary peritonitis is not known [47]. 
The etiology of IAH and ACS is multifactorial, and the initia-
tion point of the septic process is impossible to describe. 
This makes the abdominal sepsis associated IAH/ACS very 
difficult to characterize and predict in a timely fashion in 
comparison to post-injury ACS where the time of the injury 
and the beginning of the resuscitation have well-defined 
starting points. Generally, the clinical starting point for se-
vere abdominal sepsis is arbitrarily assigned to the time of 
definitive diagnosis (frequently surgery) or the time of ICU 
admission due to physiological derangements.
In addition to the potential beneficial effects seen with 
the open abdomen combined with topical negative pres-
sure (including reducing the inflammatory response and 
clearing the infection), leaving the abdomen open in severe 
secondary peritonitis reduces the risk of ACS, especially in 
patients with massive fluid resuscitation, prolonged surgery 
and visceral edema.
In a series of 78 patients with secondary peritonitis 
undergoing serial measurements of the intra-abdominal 
pressure (IAP), 32 (41%) developed IAH postoperatively [48]. 
Among the 16 patients (21%) who developed postoperative 
peritonitis (13 of them died), 12 had significantly elevated 
IAP. The authors concluded that elevated IAP postoperative-
ly can increase the risk of postoperative peritonitis and that 
postoperative IAP measurement can be used to determine 
the need of early relaparotomy.
Obviously, the relationship between abdominal sep-
sis and ACS can not be studied in isolation but needs to 
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be combined with the overall assessment of the most 
appropriate techniques of source control, potential 
benefits of deferred anastomosis (DA) and modern TAC 
methods such as the vacuum-assisted wound closure 
and mesh-mediated fascial traction (VAWCM). Perhaps 
it is time for a randomized study comparing standard 
laparotomy and ROD with OA+VAWCM+DA in severe 
secondary peritonitis?
INTENSIVE CARE AND ANTIMICROBIAL 
THERAPY
Patients with severe IAI require admission to the ICU 
either pre or post sepsis control surgery. Preoperative admis-
sion may be necessary in patients who present with overt 
organ dysfunction such as hypotension, important meta-
bolic disturbances, such as electrolyte disorders or acidosis. 
Nevertheless, source control and antibiotic therapy re-
main the cornerstones of treatment in critically ill patients 
with abdominal infections [49]. In recent years there has 
been an increased focus on the appropriate use of antibiot-
ics. Significant evidence has demonstrated that an inappro-
priate antibiotic spectrum and a delay in antibiotic initiation 
are important contributors to the morbidity and mortality 
of severe infections [50]. Although bundles have been in-
troduced in various colors and flavors, the most cited key 
factors include appropriate sampling and timely initiation of 
an appropriate spectrum of antibiotics [51]. Applying these 
principles to abdominal infections suggests that antibiotics 
should be started upon diagnosis, in the emergency room 
or ICU, without waiting for results of abdominal explora-
tion or percutaneous drainage. Although cultures are often 
considered unnecessary, it is prudent to take cultures in 
severely ill patients as antibiotic resistance, even in commu-
nity-acquired disease, is on the rise. This is also supported 
by the fact that large-scale epidemiological data are lacking 
for most hospitals, regions and countries. Despite delays in 
culture results, novel methods allow for more rapid identi-
fication making faster targeted therapy feasible. Similarly, 
de-escalation of empiric broad-spectrum antibiotic therapy 
may be guided by intraoperative cultures. Anerobic bacteria, 
though difficult to culture, should always be covered with 
initial and narrowed antibiotic therapy.
Debate continues regarding the pathogenic role of fungi 
and enterococci in these infections [52]. Both appear to be 
more frequently isolated in severe infections, and have been 
inconsistently associated with adverse outcomes. There 
seems to be consensus that enterococci should be covered 
by the initial empirical scheme. Fungal coverage is recom-
mended in cases of anastomotic leakage or when fungi are 
isolated from the intraoperative cultures [53].
Apart from the timing and spectrum of antibiotics, there 
is increasing evidence that appropriate dosing is an ad-
ditional challenge for critically ill patients with abdominal 
infections. An increased volume of distribution, enhanced 
elimination from the circulation, as well as changes in 
protein binding (largely due to lower albumin levels) all 
contribute to the unpredictable pharmacokinetics of an-
tibiotics [54]. Beta-lactam antibiotics — the mainstay of 
antimicrobial therapy for IAI — appear to be significantly 
affected. Strategies aimed at improving the pharmacoki-
netics/pharmacodynamics of antibiotic therapy include 
the use of higher doses, loading doses and extended and 
continuous infusion. However, even these strategies may 
be inadequate in some situations.
In patients with abdominal infections, the standard 
goals and treatments relevant for all critically ill patients 
apply. Particular attention should be paid to the abdominal 
compartment as these patients are at risk for a number of 
surgical complications.
The timing of source control measures is also important 
in the treatment of critically ill patients with abdominal 
infections. Generally, the presence and extent of ongoing 
contamination, the severity of clinical signs and symptoms, 
the rapidity of deterioration and the degree and dynamics of 
organ dysfunction determine the urgency of source control 
measures. Based on these concerns, three patient categories 
have been proposed [55]: 
1. Patients requiring source control as soon as possible, 
with an increased risk of mortality and significant mor-
bidity in case of delay. Examples are necrotizing fas-
ciitis and intra-abdominal infections with deteriorating 
organ function or compartment syndrome. In these 
patients, resuscitation should not be delayed but can be 
accomplished simultaneously. 
2. Patients requiring source control as soon as patient 
physiology allows. Adequate resuscitation and correc-
tion of metabolic disorders is attempted during a rea-
sonable interval prior to intervention. Most patients 
with complicated intra-abdominal infections are in this 
category.
3. Patients who do not require source control right away. 
Source control is best postponed until the inflamma-
tory process has demarcated; patients with infected 
pancreatic necrosis and patients with smaller abscesses 
that are not amenable to percutaneous drainage and 
would require high-risk open surgery would often be 
in this category.
Defining adequate resuscitation and stabilization is 
important in this context. Complete hemodynamic stabil-
ity or complete correction of metabolic disorders is often 
an elusive goal. Once a patient is no longer hypotensive (al-
beit under treatment with vasoactive drugs), is adequately 
oxygenated and major coagulopathy and acidosis has been 
corrected, a patient can be considered fit for surgery. 
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Obstacles to early source control are numerous in the 
ICU. Despite the vast array of available tools, the diagnosis 
of IAI often remains particularly challenging in the ICU pa-
tient. A lack of clinical symptoms due to sedatives or pain 
medication is probably one of the main determinants of 
delayed diagnosis. This often leads to an increased number 
of technical investigations; although access to radiologi-
cal examinations such as CT scan (or MRI — even though 
the latter rarely reveals more information than contrast 
enhanced CT scan) may often be more complex. Concomi-
tant infections are often present and blamed for clinical 
deterioration. Delay in treatment on the other hand is also 
frequent. Interventional radiology services may not readily 
be available and even surgery is sometimes delayed due to 
logistical or staffing issues during out of office hours.
Source control no longer means surgery — as an ex-
ample, interventional radiology has made considerable ad-
vances and, in pancreatitis patients, radiologic intervention 
may be the preferred initial method for obtaining source 
control [56]. This should however not minimize the benefits 
of surgery while in some patients a temporizing strategy 
may not be the optimal treatment. When selecting a source 
control modality, the benefits and risks for the patient at 
that particular moment should be carefully considered. The 
method that causes the least collateral damage in reaching 
a specific goal at a specific time is preferred. For example, 
percutaneous rather then surgical abscess drainage may 
be preferred in some situations, keeping in mind that that 
any kind of intervention may cause bleeding and additional 
organ damage. Acute cholecystitis is such an example where 
cholecystectomy (open or laparoscopic) and cholecystos-
tomy are both valuable alternatives and the condition of the 
patient will determine the optimal strategy. The intensiv-
ist, surgeon and interventional radiologist should closely 
cooperate, determine the goals of therapy and together 
determine the optimal therapeutic approach. 
Equally challenging is the problem of failed source 
control. It significantly contributes to the morbidity and 
mortality of surgical procedures as it typically occurs in 
patients who cannot tolerate additional damage and may 
increase risks for other complications. The clinical setting 
of persistent organ dysfunction and elevated inflammatory 
markers in postoperative patients should rouse suspicion of 
failed source control. Diagnosis is notoriously difficult since 
clinical examination is unreliable and abdominal CT scan is 
often equivocal. Some recent studies have provided more 
insight into this matter. A large prospective study from the 
Netherlands found that the following variables were not 
associated with failed source control on relaparotomy: the 
extent of peritonitis, the focus of infection or etiology, the 
type of contamination, nor operative variables such as the 
presence of a new anastomosis. Rather, clinical values such 
as high fever, tachycardia, low P/F ratios as well as age and 
hemoglobin value were associated with failed source control 
[57]. Procalcitonin (PCT) has also been studied in this field 
and an increase in postoperative PCT levels was predictive 
of failed source control [58].
Enteral nutritional support is important in patients with 
IAI for a number of reasons. It avoids the need for parenteral 
nutrition (PN) and has been linked to a number of improved 
outcomes. Enteral nutrition (EN) should be actively pursued 
and can be safely administered in most patients after sur-
gery. OA management is not a contraindication to enteral 
nutrition. 
A number of recent large studies have focused on the 
role of supplemental parenteral nutrition. In a general ICU 
population, adding PN to EN was associated with an increase 
in infectious complications [59]. Contrary to these findings, 
a Swiss group found that adding PN to EN in a select group 
of patients was associated with marked benefits [60]. Tar-
gets in the latter study were based on the results of indirect 
calorimetry. Notably, in the Belgian study, patients in whom 
EN was contraindicated did worse (both higher morbidity 
and mortality) when receiving PN compared to receiving 
no nutritional support [59].
These findings have further fueled the discussion as to 
who needs support and also how much. From a practical 
point of view, it appears wise to institute EN when possible, 
preferably using a protocol, in hemodynamically stable pa-
tients. Similarly, it is prudent to withhold EN when the pa-
tient is on a significant dose of vasopressors or whenever GI 
hypoperfusion is suspected. Adding PN in the first 7 days of 
ICU stay does not convey any benefit and should be avoided.
TERTIARY PERITONITIS
Tertiary peritonitis can be defined as the persistence or 
recurrence of intra-abdominal infection after apparently 
adequate treatment for primary or secondary peritonitis. It 
is characterized by organ dysfunction and prolonged sys-
temic inflammation in association with recurrent peritoneal 
infection with organisms of low intrinsic pathogenicity [61]. 
In a study of 59 patients with secondary peritonitis, 
tertiary peritonitis, defined as a culture-confirmed intra-ab-
dominal infection persisting or recurring at least 48 hours 
after apparently adequate treatment of secondary bacterial 
peritonitis, was observed in 44 patients (74%) [61]. The most 
common infecting organisms identified were Enterococcus, 
Candida, Staphylococcus epidermidis, and Enterobacter spp. 
Infectious foci were rarely amenable to percutaneous drain-
age and were found to be poorly localized at laparotomy. 
Compared with patients with uncomplicated secondary 
peritonitis, tertiary peritonitis was associated with higher 
ICU mortality (64% vs. 33%), higher organ dysfunction scores 
and ICU length of stay.
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More recent studies have grouped tertiary peritonitis 
among “complicated” intra-abdominal infections. These in-
clude persisting peritonitis despite adequate surgical and 
initial antimicrobial therapy [62], “persistent and tertiary 
chronic” peritonitis with distinct changes in immuno-re-
sponsiveness [63], and where there has been a prolonged 
course with microbiological shift from aerobic gram-neg-
ative bacteria towards gram-positive bacteria over time 
[64]. In a study of 69 patients with secondary peritonitis 
among whom 15 patients (22%) developed tertiary peri-
tonitis, transition to tertiary peritonitis was associated with 
a higher Mannheim Peritonitis Index at the initial operation, 
higher severity of illness scores and CRP levels on the second 
postoperative day, higher relaparotomy rates with increased 
mortality (60% vs. 9%), and a longer ICU length of stay [65].
Specifically, Candida peritonitis seems to be increasing 
in incidence and continuing to be associated with high 
mortality. Factors that have been identified with increas-
ing risk of development of Candida peritonitis include hol-
low viscus perforation, abdominal and thoracic surgery, 
surgical drains in situ, intravenous and urinary catheters, 
total parenteral nutrition, severe sepsis, antibiotic therapy 
more than 48 hours before peritonitis, immunosuppression, 
diabetes mellitus and extensive Candida colonization [66].
In future, tertiary peritonitis needs to be defined more 
clearly, perhaps utilizing some immunological markers. Fur-
thermore, it would be interesting to see whether staged 
repair in severe secondary peritonitis would be associated 
with a lower risk of tertiary peritonitis.
CONCLUSIONS
Timely surgical or non-surgical source controlling in-
tervention geared to the pathophysiological state of the 
patient, the appropriate use of antimicrobial agents and 
early intensive care offer the best chance of survival for pa-
tients with abdominal sepsis. The essential goal of surgical 
intervention is controlling the source of contamination. First 
demonstrated in major trauma patients, the introduction of 
damage control to the management of secondary peritonitis 
represents a paradigm shift. Although limited and repeated 
surgical interventions have been shown to be safe, the actual 
benefits need to be demonstrated in controlled studies. 
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